mM DTT,
0.1 mM PMSF, and 30% glycerol.
Molecular mass: ∼69 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 507–687 nmol/min/mg (see Figure 2)
Precautions and Disclaimer
This
London, UK: 1996), pp. 687-695.
3. Afeltra, J., and Verweij, P. E., Antifungal activity of
nonantifungal drugs. Eur. J. Clin. Microbiol. Infect.
Dis., 22(7), 397-407 (2003).
4. Mathie, A., et al.
Biol. 12, 69-78.
2. Watanabe, H., Yamada, Y. And Kimata, K. (1998) J. Biochem. 124, 687-693.
3. Doege, K.J., Sasaki, M., Kimura, T. and Yamada, Y. (1991) J. Biol. Chem. 266, 894-
902.
4. Hardingham
and
Sullenger, B.A. Retargeting mobile group II introns to repair mutant genes.
Mol. Ther. 11(5), 687-689 (2005).
6. Perutka, J., Wang, W., Goerlitz, D., Lambowitz, A.M. Use of computer-designed
group
ivermectin: Parasiticidal
effects and long-term treatment outcomes. Vet Parasitol 2014;
205: 687–696.
16. Iio A, Motohashi T, Kunisada T et al. Preferential gene transcrip-
tion of T helper 2 cytokines
(a and ?) S3396 6708 SPTA1 M NP_003117.2 y n/d n/d
412 LKB1 L7917 6794 STK11 P NP_000446.1 y y y
687 Striatin S0696 6801 STRN P NP_003153.2 n/d y y
472 Munc-18-1 M2694 6812 STXBP1 P NP_001027392.1
(a and ?) S3396 6708 SPTA1 M NP_003117.2 y n/d n/d
412 LKB1 L7917 6794 STK11 P NP_000446.1 y y y
687 Striatin S0696 6801 STRN P NP_003153.2 n/d y y
472 Munc-18-1 M2694 6812 STXBP1 P NP_001027392.1
(a and ?) S3396 6708 SPTA1 M NP_003117.2 y n/d n/d
412 LKB1 L7917 6794 STK11 P NP_000446.1 y y y
687 Striatin S0696 6801 STRN P NP_003153.2 n/d y y
472 Munc-18-1 M2694 6812 STXBP1 P NP_001027392.1
29 S2069 P n/d y y
684 Sos1 S2937 P y n/d n/d
685 Sp1 S9809 P y n/d n/d
686 Spred-2 S7320 P y y y
687 Striatin S0696 P n/d y y
688 Substance P Receptor S8305 P y y y
689 SMAC/Diablo
R WB Rb 100 µg AB16531 $220
Caspase 14
Anti-Caspase 14, clone 8-1-71 H WB M IgG1κ 100 µg 05-687 $319
Cathepsin
Anti-Cathepsin B M R WB IH Rb IgG 400 µg 06-480 $319
Spred-2 S7320 200734, 114716, 305539 Spred2,SPRED2 NP_861449.1,NP_277058.1,NP_001040559.1 P y y y
687 Striatin S0696 29149, 6801, 268980 STRN,Strn NP_062021.1,NP_003153.2,NP_035630.2 P n/d y y
688 Substance
Spred-2 S7320 200734, 114716, 305539 Spred2,SPRED2 NP_861449.1,NP_277058.1,NP_001040559.1 P y y y
687 Striatin S0696 29149, 6801, 268980 STRN,Strn NP_062021.1,NP_003153.2,NP_035630.2 P n/d y y
688 Substance
p38α/SAPK2a (6His-tag), unactive KA 50 µg 14-588
p38α/SAPK2a (T106M), active KA Pur 10 µg 14-687
p38β2/SAPK2b2, active KA 10 µg 14-253
p38γ/SAPK3, active KA 10 µg 14-246
p38δ/SAPK4, active